Cargando…

Dydrogesterone as an Option in the Medical Treatment of Endometriosis: A Brief Comment

Detalles Bibliográficos
Autor principal:	Carvalho, Bruno Ramalho de
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda. 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948048/ https://www.ncbi.nlm.nih.gov/pubmed/35839819 http://dx.doi.org/10.1055/s-0042-1751075

Ejemplares similares

Dydrogesterone in the treatment of endometriosis: evidence mapping and meta-analysis
por: Peng, Chao, et al.
Publicado: (2021)

The Effect of Letrozole Combined with Dydrogesterone for Endometriosis in China: A Meta-Analysis
por: Sun, Shumei, et al.
Publicado: (2021)

A comparative study between Dydrogesterone alone and combined with Non-Steroidal Anti-Inflammatory Drugs in the treatment of Mild Endometriosis
por: Xue, Hui-ling, et al.
Publicado: (2023)

A systematic review of dydrogesterone for the treatment of threatened miscarriage
por: Carp, Howard
Publicado: (2012)

Comparison of Dydrogesterone and GnRH-a Effects After Laparoscopic Surgery in Patients with Stage III and IV Endometriosis
por: Deng, Ting, et al.
Publicado: (2023)

Endometriosis: A Disease with Few Direct Treatment Options
por: França, Patricia Ribeiro de Carvalho, et al.
Publicado: (2022)

The Future of Luteal Phase Support in ART and the Role of Dydrogesterone
por: Drakopoulos, Panagiotis, et al.
Publicado: (2021)

Corifollitropin alpha, clomiphene citrate and dydrogesterone without daily gonadotrophin: a new option of a friendly protocol for high-responder oocyte donors
por: de Melo, Anderson Sanches, et al.
Publicado: (2022)

Different Effects of Oral Contraceptive and Dydrogesterone Treatment on Oxidative Stress Levels in Premenopausal Women
por: Chen, Jui-Tung, et al.
Publicado: (2018)

Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding – ovulation dysfunction patients
por: Wang, Lu, et al.
Publicado: (2020)

Metformin as a Potential Treatment Option for Endometriosis
por: Kimber-Trojnar, Żaneta, et al.
Publicado: (2022)

The Role of Dydrogesterone in the Management of Luteal Phase Defect: A Comprehensive Review
por: Muneeba, Shaikh, et al.
Publicado: (2023)

Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth
por: Alizadeh, Fahimeh, et al.
Publicado: (2022)

Cervical and Vaginal Microbiomes in Early Miscarriages and Ongoing Pregnancy with and without Dydrogesterone Usage
por: Gryaznova, Mariya, et al.
Publicado: (2023)

Management of endometriosis-related infertility: Considerations and treatment options
por: Lee, Dayong, et al.
Publicado: (2020)

The effects of dydrogesterone treatment on first-trimester aneuploidy screening markers and nuchal translucency in women with threatened miscarriage
por: Yıldız, Elif, et al.
Publicado: (2023)

Increased Live Birth Rate with Dydrogesterone among Patients with Recurrent Pregnancy Loss Regardless of Other Treatments
por: Bashiri, Asher, et al.
Publicado: (2023)

Development of relugolix combination therapy as a medical treatment option for women with uterine fibroids or endometriosis
por: Arjona Ferreira, Juan C., et al.
Publicado: (2022)

Corrigendum to “Management of endometriosis-related infertility: Considerations and treatment options”
por: Lee, Dayong, et al.
Publicado: (2020)

The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis
por: Lee, Hee Joong, et al.
Publicado: (2017)

Additional dydrogesterone for the treatment of chronic endometritis treated with antibiotic in premenopausal women with endometrial polyps: a retrospective cohort study
por: Liu, Yue, et al.
Publicado: (2022)

Efficacy and safety of Gushen Antai Pills combined with dydrogesterone in the treatment of threatened miscarriage: a systematic review and meta-analysis
por: Chen, Kai, et al.
Publicado: (2023)

The Addition of Dydrogesterone after Frozen Embryo Transfer in Hormonal Substituted Cycles with Low Progesterone Levels
por: Metello, Jose, et al.
Publicado: (2022)

Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response
por: Zhang, Junwei, et al.
Publicado: (2021)

An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open‐label multicenter clinical study
por: Kitawaki, Jo, et al.
Publicado: (2021)

Formulation and characterization of thiolated chitosan/polyvinyl acetate based microneedle patch for transdermal delivery of dydrogesterone
por: Khalid, Amna, et al.
Publicado: (2023)

Brief Review of Endometriosis and the Role of Trace Elements
por: Osuchowska-Grochowska, Ida, et al.
Publicado: (2021)

A randomized, double blinded, placebo controlled trial of oral dydrogesterone supplementation in the management of preterm labor
por: Areeruk, Wilasinee, et al.
Publicado: (2016)

Comparison of oral dydrogesterone with vaginal progesteronefor luteal support in IUI cycles: a randomized clinical trial
por: Khosravi, Donya, et al.
Publicado: (2015)

Effect of Dydrogesterone on the Outcome of Idiopathic Intrauterine Growth Restriction: A Double-blind Clinical Trial Study
por: Zarean, Elaheh, et al.
Publicado: (2018)

Medication Treatment for Opioid Use Disorders:: A Brief Overview with Comments on Extended Release Naltrexone
por: Woody, George
Publicado: (2017)

Sacral neuromodulation in endometriosis – A promising treatment option for chronic pelvic pain
por: Zegrea, Adrian, et al.
Publicado: (2023)

Effects of Dydrogesterone Tablets Combined with Zishen Yutai Pills on Threatened Abortion in Early Pregnancy and Pregnancy Outcomes
por: Chen, Xuehong, et al.
Publicado: (2022)

The efficacy of dydrogesterone use to suppress premature luteinizing hormone surge on cycle outcomes in controlled ovarian stimulation
por: Doğan Durdağ, Gülşen, et al.
Publicado: (2021)

Impact of Medical and Surgical Treatment of Endometriosis on the Cure of Endometriosis and Pain
por: Mettler, Liselotte, et al.
Publicado: (2014)

Clinical Efficacy, Pharmacokinetics, and Safety of the Available Medical Options in the Treatment of Endometriosis-Related Pelvic Pain: A Scoping Review
por: Mikuš, Mislav, et al.
Publicado: (2023)

Oral dydrogesterone as an adjunctive therapy in the management of preterm labor: a randomized, double blinded, placebo‐controlled trial
por: Thongchan, Suparudeewan, et al.
Publicado: (2021)

Endometriosis: An Inflammatory Disease That Requires New Therapeutic Options
por: Donnez, Jacques, et al.
Publicado: (2022)

Novel diagnostic options for endometriosis – Based on the glycome and microbiome
por: Kovács, Zsuzsanna, et al.
Publicado: (2021)

Retracted: Effects of Dydrogesterone Tablets Combined with Zishen Yutai Pills on Threatened Abortion in Early Pregnancy and Pregnancy Outcomes
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sol629i78hgt5r4cp73sdjokcd